Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study

Correction to: Eye (2013), 27, 709–715; doi:10.1038/eye.2013.8; published online 1 March 2013

Since the publication of the above article, it has been noted that a line appeared incorrectly between RETREATMENT WITH RANIBIZUMAB 0.5 mg and YES in Figure 1. In addition, Perform FA and Is leakage evident on FA? incorrectly appeared in separate boxes. The correct figure appears below.

Figure 1
figure1

REPAIR retreatment algorithm.

The authors would like to apologise for this error.

Additional information

The online version of the original article can be found at 10.1038/eye.2013.8

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tufail, A., Patel, P., Sivaprasad, S. et al. Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study. Eye 28, 365 (2014). https://doi.org/10.1038/eye.2014.11

Download citation

Further reading